Olympus

What Olympus does

Olympus Corporation, founded in 1919 and headquartered in Tokyo (Shinjuku), Japan, is a publicly listed global medical technology company (Tokyo Stock Exchange ticker 7733) that manufactures and sells medical endoscopes, endotherapy devices, and surgical energy and instrumentation products for minimally invasive diagnosis and treatment. Its core technology stack rests on proprietary optical imaging (Narrow Band Imaging, Auto Fluorescence Imaging, multilayer optical film coatings) integrated with a 4K surgical imaging platform (VISERA S), a comprehensive surgical energy portfolio (ESG-410 platform powering POWERSEAL advanced bipolar, THUNDERBEAT hybrid, and SONICBEAT ultrasonic devices), single-use endoscopy (RenaFlex ureteroscope), and — most recently — a cloud-based AI computer-aided detection system (CADDIE) developed by wholly-owned subsidiary Odin Vision for real-time colorectal polyp detection.

The company operates a direct, enterprise field sales model through regional subsidiaries (Olympus Corporation of the Americas in Center Valley, PA; Olympus Europa SE & Co. KG in Germany; Asia Pacific offices), serving hospitals, gastroenterologists, urologists, and general and specialty surgeons across 19+ countries. Revenue is generated primarily through capital equipment sales, recurring consumables tied to installed platforms, and a global service network of more than 200 repair centers. The company has 10,000+ employees globally (4,500+ in the Americas alone), multiple manufacturing plants in Japan (Aomori, Aizu, Shirakawa, Nagano/Ina, Hinode), and reports an adjusted operating margin expansion from 9.2% in FY2019 to 20.0% in FY2023 under its Transform Olympus corporate transformation program. Recent strategic activity includes FDA 510(k) clearances for the CADDIE AI system and RenaFlex ureteroscope in 2024, the acquisition of BioProtect Ltd. (urological/prostate cancer technologies, completed June 2026), and the divestiture of non-core businesses (cameras/audio to OM Digital Solutions in 2021; Life Science and Industrial Solutions to Evident in 2025).

Name

Olympus

Legal name

Olympus Corporation

Website

https://olympus-global.com

Company type

Public

Founded year

1919

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Olympus Corporation is a Japan-headquartered global medical technology company that manufactures endoscopes, endotherapy devices, and surgical energy instruments, serving hospitals, gastroenterologists, urologists, and surgeons across 19+ countries through direct enterprise sales and a 200+ service center network.

Ownership category

akta.pro rank

Product category

Medical Endoscopy and Surgical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)

akta.pro secondary industries

Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN), Reprocessing & Endoscope Infection Prevention (AERs, Drying/Storage, Leak Testing, Brushes) (HLAHANAJ)

Keywords

• Medical endoscopy systems
• Surgical energy devices
• Urology equipment
• Minimally invasive surgery
• Medical imaging platforms

Headquarters

HQ city

Shinjuku

HQ country

Japan

HQ region

Asia

Offices14 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Medical Endoscopy Equipment Sales: Olympus generates primary revenue from selling medical endoscopes, endotherapy devices, and surgical energy products to hospitals and healthcare facilities globally. Products include reusable endoscopes, single-use devices (RenaFlex ureteroscope), and surgical energy instruments (POWERSEAL family).
2. Surgical Energy Platform: ESG-410 Surgical Energy Platform powers the full range of Olympus Energy systems including monopolar, bipolar, ultrasonic, hybrid energy, and advanced bipolar devices. Revenue generated from capital equipment sales and compatible consumable devices.
3. Global Service and Repair: Olympus maintains over 200 repair centers worldwide providing maintenance and repair services for endoscopes. Global Technical Service Guidelines ensure consistent quality worldwide. Repair service quality improvement activities have reduced return rates by half.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Olympus manufactures and sells medical endoscopes, endotherapy devices, and therapeutic energy (surgical) devices for minimally invasive diagnosis and treatment. Its portfolio spans gastrointestinal endoscopy systems, surgical energy instruments (POWERSEAL, THUNDERBEAT, SONICBEAT, ESG-410 platform), urology devices (RenaFlex single-use ureteroscope), and the AI-enabled Intelligent Endoscopy Ecosystem featuring the CADDIE cloud-based computer-aided detection system for real-time polyp detection during colonoscopy.

Product overview

Olympus is a global medical technology company focused on medical endoscopes, endotherapy devices, and therapeutic energy devices. The product portfolio centers on endoscopy solutions including the VISERA S 4K imaging platform and the Intelligent Endoscopy Ecosystem featuring cloud-based AI capabilities through the CADDIE computer-aided detection system. The surgical energy portfolio includes the POWERSEAL advanced bipolar sealing devices, THUNDERBEAT hybrid energy, and SONICBEAT ultrasonic dissectors, all powered by the ESG-410 Surgical Energy Platform. In urology, Olympus offers the RenaFlex single-use flexible ureteroscope, the CV-S1 Video System Center, and recently acquired BioProtect to expand urological technologies. The company also provides the OLYMPUS CONTINUUM platform for healthcare professional education and training.

Differentiator

Problem solved

Functional benefit

Brands

• VISERA S: New imaging platform launched in September 2024 for endoscopic diagnosis and therapy.
• POWERSEAL
• RenaFlex
• CADDIE
• THUNDERBEAT
• SONICBEAT
• OLYMPUS CONTINUUM

Products and services

• VISERA S Imaging Platform 4K imaging platform launched in September 2024 for enhanced visualization during endoscopic diagnosis and surgical procedures.
• CADDIE Computer-Aided Detection System Cloud-based AI Computer-Aided Detection (CADe) device for real-time polyp detection during colonoscopy procedures. FDA-cleared and CE-marked. Analyzes colonoscopy video in real-time and provides visual markers alerting endoscopists to suspected polyp locations.
• POWERSEAL Sealer/Divider Family Advanced bipolar surgical energy devices for vessel sealing, dissection, and grasping during laparoscopic or open surgery. Available in three jaw designs (Curved Jaw Double-action, Straight Jaw Double-action, Curved Jaw Single-action) and three shaft lengths. Consistent 7mm vessel sealing with greater than 99% probability of burst pressure above 360 mmHg.
• ESG-410 Surgical Energy Platform Surgical energy platform that powers the full range of Olympus Energy systems including monopolar, bipolar (HiQ, HICURA, PK, Everest), ultrasonic (SONICBEAT), hybrid energy (THUNDERBEAT), and advanced bipolar (POWERSEAL) devices.
• THUNDERBEAT Hybrid Energy Devices Hybrid energy surgical devices combining bipolar and ultrasonic energy for enhanced dissection and sealing capabilities during surgical procedures.
• SONICBEAT Ultrasonic Dissectors Ultrasonic surgical dissectors for tissue dissection and coagulation during laparoscopic procedures.
• RenaFlex Single-use Flexible Ureteroscope System FDA 510(k) cleared single-use flexible ureteroscope system for diagnostic and therapeutic procedures within the urinary tract, including kidney stone management. Features 9.5Fr outer diameter, 3.6Fr working channel, 270-degree up/down angulation, and advanced camera chip with 120-degree field of view.
• Aplio i800 EUS (Endoscopic Ultrasound) Endoscopic ultrasound (EUS) system for visualization and diagnosis. FDA-cleared with sales activities in Europe, Japan, and Oceania.
• 4K LCD Monitors 4K LCD monitors launched June 2026 for enhanced clarity in endoscopic diagnosis and therapy.
• 4K Camera Head for Urological Endoscopy 4K camera head designed for urological endoscopy procedures, launched in September 2024.
• OLYMPUS CONTINUUM Education Platform Healthcare professional education and training platform providing educational content for healthcare professionals on Olympus medical products and procedures.
• Intelligent Endoscopy Ecosystem Olympus AI-powered digital endoscopy ecosystem leveraging cloud connectivity and AI capabilities. Includes CADDIE device and supports doctors and hospitals in addressing cost pressures and staff shortages in the context of aging population.

Quantifiable outcome

• 7.3% absolute increase in adenoma detection rate using CADDIE AI-assisted colonoscopy
• +5 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Partnerships

One partnership is on record.

• Odin Medical Ltd. / Odin VisioncoreStrategic or Co-development Partner · 5 September 2024Odin Medical Ltd., trading as Odin Vision, is a Cloud AI endoscopy company and wholly-owned subsidiary of Olympus. Developed the CADDIE cloud-based AI computer-aided detection device for colonoscopy that received FDA 510(k) clearance. CEO Peter Mountney stated cloud technology enables hospitals to stay current with AI advances. The company represents Olympus's digital transformation strategy in endoscopy.

Scale indicators10 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• CONMED: Specialty surgical and endoscopy device company directly competing with Olympus in advanced energy and GI/specialty endoscopy consumables and capital equipment.
• Fujifilm Healthcare: Fujifilm's Healthcare division sells endoscopy systems (including its own AI colonoscopy offerings) and competes directly with Olympus in GI endoscopy imaging and processing.
• Karl Storz: German family-owned medical device company and the other global leader in endoscopy systems and visualization, directly competing with Olympus in rigid and flexible endoscopes across surgical specialties.
• Pentax Medical (HOYA): HOYA's Pentax Medical division develops flexible endoscopy systems for GI and ENT, directly overlapping Olympus's GI and urology endoscopy portfolios.

Broad incumbents

• Boston Scientific: Broad medtech incumbent with significant presence in endoscopy (single-use scopes, hemostasis), urology, and surgical energy — overlapping with Olympus across multiple therapeutic areas.
• Intuitive Surgical: Dominant minimally invasive surgical robotics (da Vinci) incumbent that competes in the same OR budgets and laparoscopic procedure volumes as Olympus's surgical energy devices.
• Johnson & Johnson (Ethicon): J&J's Ethicon division is a leading surgical energy and advanced instrumentation competitor with overlapping laparoscopic energy devices like Harmonic and Enseal.
• Stryker: Large medtech incumbent competing in surgical visualization, energy, and OR integration; overlapping with Olympus's surgical energy and imaging-platform business units.
• Medtronic: Diversified medtech incumbent whose GI Genius AI polyp detection system and PillCam capsule endoscopy directly compete with Olympus's CADDIE and GI endoscopy franchise.

Emerging players

• Covis (Micro-Tech): Emerging player in endotherapy and single-use endoscopy accessories, competing with Olympus's biopsy and therapeutic device portfolio in gastroenterology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/olympus_corp
• YouTubeyoutube.com/olympus
• Facebookfacebook.com/OlympusMedicalCorp
• LinkedInlinkedin.com/company/olympus-corp
• Instagraminstagram.com/olympus

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Olympus